Board committees
Board of Directors:

Anders Ekblom
Chairman of the Board
Chairman of the Board since 2021
Chairman of the Remuneration Committee
Born 1954
Education: M.D., Board certified in Anesthesiology and Intensive Care, D.D.S., Associate Professor in Physiology, Karolinska Institutet
Other current activities:
Chairman of the Board of Alligator Bioscience AB, and Atrogi AB, Member of the Board of Synkerkine Pharma B.V., Flerie AB, Mereo BioPharma Group plc, and NxtScience AB, and Deputy director of Xspray Pharma Futurum AB
Holdings: 5,500 shares, 13 214 warrants (LTIP 2021/2026)
Independent in relation to the Company and its management, but not in relation to major shareholders

Anders Bladh
Board member since 2021
Member of the Remuneration Committee
Born 1958
Education: Bachelor of Science in Business Administration and Economics, University of Uppsala
Other current activities:
Owner and Chairman of the Board of Intervalor AB, Chairman of the Board of DistIT AB, Member of the Board of Ribbskottet AB, Rimturs AB, and Umecrine Cognition AB
Holdings: 274,670 shares, and 4,300,000 shares via company Ribbskottet AB
Independent in relation to the Company and its management, but not in relation to major shareholders.

Markus Haeberlein
Board member
Board member since 2025
Resides in the USA
Born 1969
Education: M.Sc. and Ph.D. in Physical Chemistry/Computational Chemistry from Royal Institute of Technology, KTH, Stockholm
Other current activities:
Executive Vice President , Discovery Science at Parabilis Medicines, Cambridge, Massachusetts, USA
Holdings in Xspray Pharma: 0
Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind
Board member
Board member since 2019
Chairman of the Audit Committee
Born 1974
Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School
Other current activities:
Other current activities: CEO of Bactiguard AB, and Bactiguard Holding AB, Chairman and CEO of Lind Growth Strategy AB, Member of the Board of Shinka Life Sciences AB
Holdings: 7,368 shares
Independent in relation to the Company and its management and in relation to major shareholders

Robert Molander
Board member
Board member since 2022
Resides in the USA
Born 1965
Education: MBA from Washington University and two bachelor’s degrees from Miami University in Economics and International Studies
Other current activities:
Owner and CEO of Stratfox Healthcare Group LLC, partner of IRL MD Food Solutions, and Member of the Board of SciBase Intressenter AB, SciBase Holding AB (publ), SciBase AB, and Biosergen AB
Holdings: 10,000 shares
Independent in relation to the Company and its management and in relation to major shareholders

Anne Prener
Board member
Board member since 2025
Resides in Denmark
Born 1957
Education: M.D., PhD. from Copenhagen University
Other current activities:
Senior Innovation Advisor at University of Copenhagen, non-executive Board member of Galecto Inc.
Holdings: 0
Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak
Board member
Board member since 2015
Member of the Audit Committee
Born 1956
Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet
Other current activities:
Member of the Board of Atrogi AB, EpiEndo ehf, Lipum AB, Symcel AB, and Buzzard Pharmaceuticals AB
Holdings: 0
Independent in relation to the Company and its management and in relation to major shareholders
Committees:
Audit Committee
- Christine Lind, Chairman
- Anne Prener
- Carl-Johan Spak
Remuneration Committee
- Anders Ekblom, Chairman
- Anders Bladh
- Robert Molander